22nd Century
Invited to Speak at the Colorado Hemp Expo about the Company's Medical
Marijuana Initiatives and Zero-THC Hemp Plants
CLARENCE, N.Y. - March 29, 2017
(Investorideas.com Newswire) 22nd Century Group, Inc. (NYSE MKT:XXII), a leader
in tobacco harm reduction and cannabis research, announced today that
representatives of the Company's wholly-owned subsidiary, Botanical Genetics,
have been invited to serve as featured speakers and presenters at the annual
Colorado Hemp Expo at the Ranch Events Complex, 5260 Arena Circle, Loveland,
Colorado on Friday, March 31, 2017, and Saturday, April 1, 2017.
Dr. Paul Rushton, Vice President of
Plant Biotechnology, and Thomas James, Esq., Vice President & General
Counsel, will provide conference attendees with business and scientific updates
and highlights of 22nd Century's advances in the rapidly evolving legal medical
marijuana and industrial hemp markets. Headlining the presentation will be Dr.
Rushton's featured speech on Friday evening regarding the Company's proprietary
cannabis initiatives, including the Company's recently announced development of
THC-free industrial hemp plants and the propagation of medical marijuana
strains that are selected for increased levels of medically-important
cannabinoids, such as CBC and CBD. Dr. Rushton will also speak in a panel
discussion on Seeds, Clones, Pesticides and Pollen at the conference. Mr. James
will speak on three panel discussions: Investments in Hemp, Global Hemp
Activities, and The Future of Hemp. Dr. Rushton, Mr. James and other
representatives of the Company will be available for one-on-one meetings
throughout the conference.
"We are developing several
exciting new strains of medical marijuana as well as industrial hemp varieties
with substantially altered levels of cannabinoids - all of which will be below
the legal limit of 0.3% THC," explained Dr. Rushton. "Following our
recently announced success with Zero-THC hemp plants and our major
collaboration with the University of Virginia, Botanical Genetics is now
aggressively expanding our activities in an effort to make our Company a major
source of proprietary plants for both the legal medical marijuana and
industrial hemp markets. We look forward to exploring exciting business
opportunities with like-minded companies in Colorado."
About 22nd Century
Group, Inc.
22nd Century is a plant biotechnology
company focused on technology which allows us to increase or decrease the level
of nicotine in tobacco plants and the level of cannabinoids in cannabis plants
through genetic engineering and plant breeding. The Company's primary mission
in tobacco is to reduce the harm caused by smoking. The Company's primary
mission in cannabis is to develop proprietary cannabis strains for important
new medicines and agricultural crops. 22nd Century currently owns or
exclusively controls more than 200 issued patents and more than 50 pending
patent applications around the world. For more information, visit www.xxiicentury.com and www.botanicalgenetics.com.
Cautionary Note Regarding
Forward-Looking Statements: This press release contains forward-looking
information, including all statements that are not statements of historical
fact regarding the intent, belief or current expectations of 22nd Century
Group, Inc., its directors or its officers with respect to the contents of this
press release, including but not limited to our future revenue expectations.
The words "may," "would," "will,"
"expect," "estimate," "anticipate,"
"believe," "intend" and similar expressions and variations
thereof are intended to identify forward-looking statements. We cannot
guarantee future results, levels of activity or performance. You should not
place undue reliance on these forward-looking statements, which speak only as
of the date that they were made. These cautionary statements should be considered
with any written or oral forward-looking statements that we may issue in the
future. Except as required by applicable law, including the securities laws of
the United States, we do not intend to update any of the forward-looking
statements to conform these statements to reflect actual results, later events
or circumstances, or to reflect the occurrence of unanticipated events. You
should carefully review and consider the various disclosures made by us in our
annual report on Form 10-K for the fiscal year ended December 31, 2016, filed
on March 8, 2017, including the section entitled "Risk Factors," and
our other reports filed with the U.S Securities and Exchange Commission which
attempt to advise interested parties of the risks and factors that may affect
our business, financial condition, results of operation and cash flows. If one
or more of these risks or uncertainties materialize, or if the underlying
assumptions prove incorrect, our actual results may vary materially from those
expected or projected.
Contacts
22nd Century Group, Inc.
Investor Relations:
IRTH Communications
Andrew Haag, 866-976-4784
xxii@irthcommunications.com
Investor Relations:
IRTH Communications
Andrew Haag, 866-976-4784
xxii@irthcommunications.com
Watch the 420
Cannabis Investor video
More Info:
This news is published on the
Investorideas.com Newswire - a global digital news source for investors and
business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
No comments:
Post a Comment